Authorities in India have identified a batch of the Abhayrab rabies vaccine as substandard and have launched a probe to determine if it is spurious. The action highlights ongoing concerns regarding medical .
Under Investigation
Status
The Indian government has flagged a specific batch of the Abhayrab rabies vaccine as substandard, triggering a probe into whether the products are counterfeit. This discovery comes as a blow to local medical safety efforts, highlighting potential lapses in quality control and distribution networks. Authorities are now investigating the supply chain to ensure that no further tainted doses reach healthcare facilities. For patients, this serves as a reminder to verify the origin and certification of essential medication. The incident has also raised questions for the manufacturers involved, who are now under pressure to provide full transparency on their production and safety protocols to restore public trust in critical immunization programs.
💭 If you're wondering…
Always purchase from reputable, licensed pharmacies and check for original holographic seals or use brand-provided verification apps if available.
Did this story help?
Official sources
Knowledge Chain — tap a concept